Top

Supportive Care in Cancer

Published in:

01-04-2004 | Original Article

Cancer: disease and nutrition are key determinants of patients’ quality of life

Authors: Paula Ravasco, Isabel Monteiro-Grillo, Pedro Marques Vidal, Maria E. Camilo

Published in: Supportive Care in Cancer | Issue 4/2004

Abstract

Goals of work

The aims of this study were (1) to evaluate quality of life (QoL), nutritional status and dietary intake taking into account the stage of disease and therapeutic interventions, (2) to determine potential interrelationships, and (3) to quantify the relative contributions of the cancer, nutrition and treatments on QoL.

Patients and methods

In this prospective cross-sectional study conducted in 271 head and neck, oesophagus, stomach and colorectal cancer patients, the following aspects were evaluated: QoL (EORTC-QLQ C30), nutritional status (percent weight loss over the previous 6 months), usual diet (comprehensive diet history), current diet (24-h recall) and a range of clinical variables.

Main results

Usual and current intakes differed according to the site of the tumour (P=0.02). Patients with stage III/IV disease showed a significant reduction from their usual energy/protein intake (P=0.001), while their current intakes were lower than in patients with stage I/II disease (P=0.0002). Weight loss was greater in patients with stage III/IV disease than in those with stage I/II disease (P=0.001). Estimates of effect size revealed that QoL function scores were determined in 30% by cancer location, in 20% by nutritional intake, in 30% by weight loss, in 10% by chemotherapy, in 6% by surgery, in 3% by disease duration and in 1% by stage of disease. Likewise in the case of symptom scales, 41% were attributed to cancer location, 22% to stage, 7% to nutritional intake, 7% to disease duration, 4% to surgery, 1% to weight loss and 0.01% to chemotherapy. Finally for single items, 30% were determined by stage, 20% by cancer location, 9% by intake, 4% by surgery, 3% by weight loss, 3% by disease duration and 1% by chemotherapy.

Conclusions

Although cancer stage was the major determinant of patients’ QoL globally, there were some diagnoses for which the impact of nutritional deterioration combined with deficiencies in nutritional intake may be more important than the stage of the disease process.

Cravo ML, Glória ML, Claro I (2000) Metabolic responses to tumour disease and progression: tumour-host interaction. Clin Nutr 19:459–465CrossRefPubMed

Van der Schueren MAEB, Van Leeuwen PAM, Kuik DJ, et al (1999) The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86:519–527CrossRefPubMed

Grosvenor M, Bulcavage L, Chlebowski R (1989) Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63:330–334PubMed

Hansell DT, Davies J, Burns HJ (1986) The effects on resting energy expenditure of different tumor types. Cancer 58:1739–1744PubMed

Ferrell BR, Dow KH, Grant M (1996) Measurement of quality of life in cancer survivors. Qual Life Res 4:523–531

King’s Fund (1992) A positive approach to nutrition as treatment. King’s Fund Centre, London

Vetta F, Ronzoni S, Taglieri G, Bollea MR (1999) The impact of malnutrition on the quality of life in the elderly. Clin Nutr 18:259–267PubMed

Ottery F (1996) Definition of standardised nutritional assessment and interventional pathways in oncology. Nutrition 12:s15–s19CrossRefPubMed

Sobin L, Ch W (1997) UICC TNM classification of malignant tumours. Willey, New York

10.

Longo D (1998) Approach to the patient with cancer. In: Fauci A, Braunwald E, Isselbacher K, et al (eds) Harrison’s principles of internal medicine, 14th edn. McGraw Hill, New York, pp 493–499

11.

ASPEN Board of Directors (2002) Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr [Suppl] 26:9SA–11SA

12.

WHO (1985) Energy and protein requirements (Technical Report Series). WHO, Geneva

13.

Owen OE, Kavle E, Owen RS (1986) A reappraisal of the caloric requirements in healthy women. Am J Clin Nutr 44:1–19PubMed

14.

Owen OE, Holup JL, D’Alessio DA, et al (1987) A reappraisal of the caloric requirements of men. Am J Clin Nutr 46:875–885PubMed

15.

Garrel DR, Jobin N, De Jonge LHM (1996) Should we still use the Harris and Benedict equations? Nutr Clin Pract 11:99–103PubMed

16.

Food and Nutrition Board Institute of Medicine (2002) Dietary reference intakes for energy, carbohydrates, fiber, fat, protein and amino acids (macronutrients). National Academy Press, Washington DC

17.

Burke B (1947) The diet history as a tool in research. J Am Diet Assoc 23:1041–1046

18.

Ocké M, Kaaks R (1997) Biochemical markers as additional measurements in dietary validity studies: application of the methods of triads with examples from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 65 [Suppl 4]:1240S–1245S

19.

Whiehl D (1942) Diets of a group of aircraft workers in Southern California. Millbank Memorial Fund Q 20:329–366

20.

Aaronson NK, Ahmedzai S, Bergman B, et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMed

21.

Kern KA, Norton JÁ (1988) Cancer cachexia. JPEN J Parenter Enteral Nutr 12:286–298PubMed

22.

De Blaauw I, Deutz N, von Meyenfeldt MF (1997) Metabolic changes of cancer cachexia—second of two parts. Clin Nutr 16:223–228

23.

Van der Schueren MAE, Langendoen SI, Vondeling H, et al (2000) Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomised clinical trial. Clin Nutr 19:437–444CrossRefPubMed

24.

Roberge C, Tran M, Massoud C, et al (2000) Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer. Br J Cancer 82:263–269CrossRefPubMed

25.

de Graeff A, Leeuw RJ, Ros WJG, et al (1999) A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck 21:291–296CrossRefPubMed

26.

Padilla GV, Grant MM, Lipsett J, Anderson PR, Rhiner M, Bogen C (1992) Health quality of life and colorectal cancer. Cancer 70:1450–1456PubMed

27.

Wigmore S, Plester C, Ross AC, Fearon E (1997) Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84:196–197CrossRefPubMed

28.

Cohn S, Gartenhaus W, Vartsky D, et al (1981) Body composition and dietary intake in neoplastic disease. Am J Clin Nutr 34:1997–2004

29.

Bozzetti F, Migliavacca S, Scotti A, et al (1982) Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 196:170–179PubMed

30.

Nguyen N, Sallah S, Karlsson U, Antoine J (2001) Combined chemotherapy and radiation therapy for head and neck malignancies. Cancer 94:1131–1141CrossRef

31.

Kuntz A, Weymuller E (1999) Impact of neck dissection on quality of life. Laryngoscope 109:1334–1338

32.

Liedman B (1999) Symptoms after total gastrectomy on food intake, body composition, bone metabolism and quality of life in gastric cancer patients—is reconstruction with a reservoir worthwhile? Nutrition 15:677–682CrossRefPubMed

33.

Keys A, Brozec J, Henschel A (1950) The biology of human starvation. University of Minnesota Press, Minneapolis

34.

Ravasco P, Monteiro Grillo I, Marques Vidal P, Camilo ME (2003) Nutrition and patient outcomes: prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy. Eur J Cancer 1:S207–208

35.

Ravasco P, Monteiro Grillo I, Marques Vidal P, Camilo M (2003) Nutrition and patient outcomes: a prospective randomised controlled trial in colorectal cancer patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 57 [Suppl 2]:S220–S221

Title: Cancer: disease and nutrition are key determinants of patients’ quality of life
Authors: Paula Ravasco
Isabel Monteiro-Grillo
Pedro Marques Vidal
Maria E. Camilo
Publication date: 01-04-2004
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 4/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-003-0568-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Goals of work

Patients and methods

Main results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2004

Measuring mucosal damage induced by cytotoxic therapy

Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis

Reliability and validity of the Functional Assessment of Chronic Illness Therapy–Spiritual (FACIT–Sp) for Japanese patients with cancer

April 2004

Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline

Is a specific oncological scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer